Medical technology firm Stryker’s spine division has purchased SafeWire product portfolio, which can be used in minimally-invasive spine procedures.
The acquisition is part of Stryker spine division’s strategy to expand its product offering for minimally-invasive spine surgery.
The purchased portfolio includes the Y-Wire guidewire and Tiger Jamshidi needle family for use in minimally invasive spine surgery.
Y-Wire includes a patented feature, which is designed to mitigate potential wire-based complications such as inadvertent advancement of the guidewire through bone, accidental pullout, kinking, or wire migration.
It also helps in enhancing workflow for minimally invasive spine cases, in addition to reducing patient and surgeon exposure to fluoroscopy.
Stryker’s spine division president Brad Paddock said: "We are excited to bring this important complementary technology into the Stryker family.
"This acquisition increases our competitive advantage as we broaden our product line and extend our customer base among teaching facilities, competitive accounts, and existing SafeWire customers."
Earlier this month, Stryker completed the acquisition of Physio-Control International from private-equity firm Bain Capital for $1.28bn and Sage Products from Madison Dearborn Partners for around $2.775bn.
With operations in around 100 countries, Stryker produces products in different segments such as orthopaedics, medical and surgical, and neurotechnology and spine.